Press Releases

and/or
572 News Releases found
Immunotherapy Could Replace Surgery, Enabling Patients To Retain Their Organs and Enhance Their Quality of Life

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea Cercek, MD, and Luis Diaz Jr., MD, demonstrates how immunotherapy alone can allow people with MMRd cancers to avoid surgery and preserve their quality of life.
Memorial Sloan Kettering Cancer Center Issues Statement on Fiscal Year 2024 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2024 results.
an MSK logo on a white medical coat
MSK Awards and Appointments March 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Almudena Chaves Perez, Adriana Mujal, Hina Shah, and...
The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Announces New State-of-the-Art Cancer Care Pavilion Will Be Named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering Cancer Center Debuts “One Hundred Views” Mural in Collaboration with Artist Naomi Reis and Local P.S. 183 Fifth-Grade Students
Memorial Sloan Kettering Cancer Center Debuts “One Hundred Views” Mural in Collaboration with Artist Naomi Reis and Local P.S. 183 Fifth-Grade Students

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce a new community mural, “One Hundred Views,” by artist Naomi Reis. The inaugural MSK m...
MSK Awards and Appointments February 2025
MSK Awards and Appointments February 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Vinod Balachandran Awarded the Marcus Foundation Med...
Cycle for Survival Surpasses $400 Million Raised for Rare Cancer Research
Cycle for Survival Surpasses $400 Million Raised for Rare Cancer Research

Since 2007, Cycle for Survival donors and participants have raised more than $400 million to accelerate life-changing rare cancer research at Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering Cancer Center and AWS to Accelerate AI-Driven Cancer Innovation

Collaboration will enhance innovation and the adoption of AI in translational research with the goal of improving patient care and outcomes.
Photograph by Maegan Gindi for The Washington Post
Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod Balachandran, MD, Named to The Washington Post Next 50

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition of the Post Next 50, a list of up-and-coming changemakers shaping society in 2025.
MSK Awards and Appointments January 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.